Fidelity International
KRYS icon

Fidelity International’s Krystal Biotech KRYS Stock Holding History

Fidelity International’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-176,799
Closed -$12M – 863
2021
Q2 		$12M Buy
176,799
+865
+0.5% +$60.4K 0.01% 527
2021
Q1 		$13.6M Sell
175,934
-65,392
-27% -$4.75M 0.02% 484
2020
Q4 		$14.5M Buy
241,326
+180,350
+296% +$9.01M 0.02% 446
2020
Q3 		$2.63M Buy
60,976
+76
+0.1% +$3.3K ﹤0.01% 580
2020
Q2 		$2.52M Buy
+60,900
New +$2.93M ﹤0.01% 570

Other funds holding KRYS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fidelity International's KRYS Position: Q3 2021 in Review

Fidelity International sold out of Krystal Biotech (KRYS) in Q3 2021, closing a stake of 176,799 shares — an estimated $12M sold.

Fidelity International first reported a position in KRYS in Q2 2020 and held it in 5 quarters. The position peaked at $14.5M in Q4 2020. 113 funds tracked by Wall St. Rank hold KRYS as of Q3 2021.

  • Fidelity International reported no remaining Krystal Biotech position as of Q3 2021 after selling out during the quarter.
  • Fidelity International sold 176,799 Krystal Biotech shares in Q3 2021, an estimated $12M.
  • Fidelity International first reported a position in Krystal Biotech in Q2 2020 and held it in 5 quarters.
  • Fidelity International's Krystal Biotech position peaked at $14.5M in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2021.

Based on Fidelity International's 13F filing for Q3 2021, filed 15 Nov 2021.